Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome
Authors:
- Liselotte KokLKLiselotte Kok
- Ben J.M. WittemanBWBen J.M. Witteman
- Ruben BaumgartenRBRuben Baumgarten
- Ellen KampmanEKEllen Kampman
- Karel G.M. MoonsKMKarel G.M. Moons
- Niek J. de WitNWNiek J. de Wit
- 1 January 2008
- journal article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 46 (9) , 1275-80
Abstract
: Ruling out somatic bowel disease, such as inflammatory bowel disease (IBD), is an important goal in the management of abdominal complaints. Endoscopy is commonly used but is invasive and expensive. Mucosal inflammation in IBD can be detected through fecal biomarkers, though the present enzyme-linked immunoabsorbent assay (ELISA) tests require laboratory facilities. We validated the diagnostic performance of two new fecal rapid tests (FRTs) for the detection of calprotectin and lactoferrin and assessed their potential to differentiate IBD from irritable bowel syndrome (IBS).: The calprotectin and lactoferrin FRTs and ELISA tests were performed on the fecal samples of 114 patients referred for endoscopy, 80% of whom had IBS and 20% IBD, and validated against the endoscopic diagnosis.: The sensitivity and negative predictive value of the calprotectin FRT were both 100%, whereas they were 78% and 95%, respectively, for the lactoferrin FRT. The specificity and positive predictive value were slightly higher for the lactoferrin FRT. Both FRTs had similar diagnostic accuracy as the corresponding ELISA tests.: The calprotectin and lactoferrin rapid tests are as good as the ELISA tests in detecting colonic inflammation. Given their simple use, FRTs can support the non-invasive exclusion of IBD, notably in primary care.Clin Chem Lab Med 2008;46:1275–80.Keywords
This publication has 26 references indexed in Scilit:
- Accuracy of Four Fecal Assays in the Diagnosis of ColitisDiseases of the Colon & Rectum, 2007
- Enzymes in feces: Useful markers of chronic inflammatory bowel diseaseClinica Chimica Acta, 2007
- Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal MalignancyAmerican Journal of Gastroenterology, 2007
- Fecal Lactoferrin Is a Sensitive and Specific Marker of Disease Activity in Children and Young Adults With Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2007
- Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic diseaseInternational Journal of Colorectal Disease, 2006
- Fecal Lactoferrin Is A Sensitive and Specific Marker in Identifying Intestinal InflammationAmerican Journal of Gastroenterology, 2003
- Neutrophil Migration across the Intestinal Epithelial Barrier – Summary of in vitro Data and Description of a New Transgenic Mouse Model with Doxycycline-Inducible Interleukin-8 Expression in Intestinal Epithelial CellsPathobiology, 2002
- Utility of a Rapid Fecal Latex Agglutination Test Detecting the Neutrophil Protein, Lactoferrin, for Diagnosing Inflammatory Causes of Chronic DiarrheaAmerican Journal of Gastroenterology, 1998
- Immunochemical detection of human lactoferrin in feces as a new marker for inflammatory gastrointestinal disorders and colon cancerClinical Biochemistry, 1994
- Assessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic StudyScandinavian Journal of Gastroenterology, 1992